RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling-Reference-Cited by-同舟云学术

RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling

Published:2017-06-06 Issue:8 Volume:158 Page:2680-2693
ISSN:0013-7227
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Cegla Jaimini¹,Jones Ben J¹,Gardiner James V¹,Hodson David J²³⁴,Marjot Thomas¹,McGlone Emma R¹,Tan Tricia M¹,Bloom Stephen R¹

Affiliation:

1. Division of Diabetes, Endocrinology and Metabolism, Imperial College London W12 0NN, United Kingdom

2. Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston B15 2TT, United Kingdom

3. Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham B15 2TH, United Kingdom

4. Centre of Membrane Proteins and Receptors, University of Birmingham, Birmingham B15 2TT, and University of Nottingham, Nottingham NG7 2RD, United Kingdom

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/158/8/2680/19380458/en.2016-1755.pdf

Reference39 articles.

1. Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men;Geary;Am J Physiol,1992

2. Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency;Nair;J Clin Endocrinol Metab,1987

3. Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia;Tan;Diabetes,2013

4. Glucagon increases energy expenditure independently of brown adipose tissue activation in humans;Salem;Diabetes Obes Metab

5. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action;Rodbell;J Biol Chem,1971

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1/3 KO than in WT mice;European Journal of Pharmacology;2023-09

2. The molecular pharmacology of glucagon agonists in diabetes and obesity;Peptides;2023-07

3. Itch receptor MRGPRX4 interacts with the receptor activity–modifying proteins;Journal of Biological Chemistry;2023-05

4. Negative allosteric modulation of the glucagon receptor by RAMP2;Cell;2023-03

5. Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins;Pharmacological Reviews;2022-12-08